Global Alliance for Chronic Diseases

Global Alliance for Chronic Diseases
Name	Global Alliance for Chronic Diseases
Abbreviation	GACD
Formation	2011
Type	International research funding partnership
Headquarters	n/a
Region served	Global

Global Alliance for Chronic Diseases is an international partnership of major biomedical and public health research funders formed to coordinate and accelerate transnational research on noncommunicable diseases. The alliance brings together government agencies, philanthropic foundations, multilateral organizations, and academic institutions to target shared priorities across cardiovascular disease, diabetes, chronic respiratory disease, cancer, and mental health. Through pooled funding, joint calls, and collaborative networks, the alliance seeks to translate evidence into policy and programmatic action across diverse settings.

Background and Formation

The alliance was established following dialogues among funders including National Health and Medical Research Council, Canadian Institutes of Health Research, Medical Research Council (United Kingdom), National Institutes of Health, Australian Government, and Health Research Board (Ireland), reflecting global concern after meetings such as the World Health Assembly and the United Nations General Assembly high-level meeting on noncommunicable diseases. Early convenings involved stakeholders from World Health Organization, Bill & Melinda Gates Foundation, Wellcome Trust, European Commission, Indian Council of Medical Research, and National Heart, Lung, and Blood Institute to align priorities for implementation research, capacity building, and comparative effectiveness studies. The formation drew on precedents from consortia such as Coalition for Epidemic Preparedness Innovations, Global Fund to Fight AIDS, Tuberculosis and Malaria, and International Agency for Research on Cancer for pooled investment models.

Mission and Objectives

The alliance's mission focuses on reducing the global burden of noncommunicable diseases by funding research that informs policy in low-, middle-, and high-income contexts, engaging partners like World Bank, Pan American Health Organization, African Union, Asian Development Bank, and national ministries such as Ministry of Health (Brazil), Ministry of Health and Family Welfare (India), and Department of Health and Human Services (United States). Objectives include promoting implementation science, strengthening research capacity in settings represented by University of Cape Town, All India Institute of Medical Sciences, Imperial College London, and Harvard T.H. Chan School of Public Health, and fostering knowledge translation with stakeholders including United Nations Development Programme and Organisation for Economic Co-operation and Development. The alliance aims to catalyze multi-country studies, harmonize measurement approaches inspired by initiatives like Global Burden of Disease Study, and inform frameworks such as the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases.

Organizational Structure and Membership

Governance of the alliance features a rotating coordination model linking agencies such as National Health and Medical Research Council (Australia), Canadian Institutes of Health Research, Health Research Board (Ireland), Medical Research Council (United Kingdom), National Health and Medical Research Council of Australia, and partners from New Zealand Ministry of Health, South African Medical Research Council, Chinese Academy of Medical Sciences, and Brazilian Ministry of Health. Membership spans funders, academic partners like London School of Hygiene & Tropical Medicine, University of São Paulo, Johns Hopkins University, and implementing bodies such as Clinton Health Access Initiative and PATH (organization). Operational committees include scientific advisory groups, review panels drawing on expertise from Rockefeller Foundation, Kaiser Permanente, European Centre for Disease Prevention and Control, and ethics boards engaging representatives from UNICEF and Human Rights Watch.

Research Programs and Funding Initiatives

The alliance issues joint funding calls supporting projects across prevention, early detection, treatment, and systems research, with grant mechanisms resembling programs from National Institutes of Health, Horizon 2020, Wellcome Trust awards, and bilateral schemes like those of Australian Department of Foreign Affairs and Trade and Global Challenges Research Fund. Funded work spans trials and implementation studies in collaboration with institutions such as Karolinska Institutet, McMaster University, University of Melbourne, and Peking University Health Science Center, and leverages tools from Cochrane Collaboration, ClinicalTrials.gov, CONSORT guidelines, and measurement approaches from International Classification of Diseases. Capacity development grants target research training linked to centers including Makerere University, Federal University of São Paulo, and National University of Singapore.

Major Projects and Collaborations

Notable multi-country projects supported by the alliance have involved partnerships with World Health Organization country offices, regional entities like African Union Commission, and research networks such as Global Alliance for Vaccines and Immunisation, TDR (Special Programme for Research and Training in Tropical Diseases ), and disease-specific groups including Global Heart Initiative and Global Diabetes Compact. Collaborative trials have connected teams at University of Washington, University of Toronto, Addenbrooke's Hospital, and St John's Medical College, studying interventions ranging from tobacco control aligned with WHO Framework Convention on Tobacco Control to salt reduction strategies echoing United Nations Decade of Action on Nutrition. Implementation research projects have partnered with ministries including Ministry of Health (Ethiopia) and Ministry of Health (Mexico) to evaluate task-shifting, digital health, and community-based delivery models.

Impact, Outcomes, and Evaluations

Evaluations of alliance-funded research cite contributions to policy briefs used by World Health Organization, national guidelines adopted in countries represented by Brazil, India, South Africa, China, and economic assessments informing World Bank investment cases. Publications in journals associated with The Lancet, New England Journal of Medicine, BMJ, PLOS Medicine, and Nature Medicine have disseminated findings from trials and implementation studies led by investigators at Harvard University, University of Oxford, Stanford University, and University of Cape Town. Impact assessments reference influence on strategies aligned with Sustainable Development Goals, especially Sustainable Development Goal 3, and cite capacity strengthening evidenced by doctoral output at partner institutions like Makerere University and All India Institute of Medical Sciences.

Challenges and Future Directions

Persistent challenges include coordinating stakeholders across entities such as Gavi, the Vaccine Alliance, negotiating intellectual property arrangements with partners like GlaxoSmithKline and Pfizer, aligning timelines among funders including European Research Council and national councils, and measuring long-term population-level outcomes amid changing epidemiology captured by Institute for Health Metrics and Evaluation. Future directions emphasize scaling implementation evidence with partners such as UNICEF, integrating digital strategies used by Microsoft and Google Health, and deepening South–South collaboration among institutions including Universidade de São Paulo, University of the West Indies, and University of Nairobi to sustain impact on noncommunicable disease burden.

Category:International medical organizations